Aristeia Capital’s Cano Health, Inc. CANO Stock Holding History

Aristeia Capital’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,500	Closed	-$1.56M	–	280
2020 Q3	$1.56M	Buy	+1,500	New	+$1.57M	0.06%	152

Other funds holding CANO

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Aristeia Capital's CANO Position: Q4 2020 in Review

Aristeia Capital sold out of Cano Health, Inc. (CANO) in Q4 2020, closing a stake of 1,500 shares — an estimated $1.56M sold.

Aristeia Capital first reported a position in CANO in Q3 2020 and held it in 1 quarter. The position peaked at $1.56M in Q3 2020. 81 funds tracked by Wall St. Rank hold CANO as of Q4 2020.

Aristeia Capital reported no remaining Cano Health, Inc. position as of Q4 2020 after selling out during the quarter.
Aristeia Capital sold 1,500 Cano Health, Inc. shares in Q4 2020, an estimated $1.56M.
Aristeia Capital first reported a position in Cano Health, Inc. in Q3 2020 and held it in 1 quarter.
Aristeia Capital's Cano Health, Inc. position peaked at $1.56M in Q3 2020.
81 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2020.

Based on Aristeia Capital's 13F filing for Q4 2020, filed 16 Feb 2021.